Baillie Gifford & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-54
| Closed | -$44.4K | – | 411 |
|
2023
Q1 | $44.4K | Buy |
54
+7
| +15% | +$5.75K | ﹤0.01% | 292 |
|
2022
Q4 | $33.9K | Hold |
47
| – | – | ﹤0.01% | 310 |
|
2022
Q3 | $32K | Sell |
47
-3
| -6% | -$2.04K | ﹤0.01% | 304 |
|
2022
Q2 | $30K | Buy |
50
+4
| +9% | +$2.4K | ﹤0.01% | 310 |
|
2022
Q1 | $32K | Hold |
46
| – | – | ﹤0.01% | 313 |
|
2021
Q4 | $29K | Sell |
46
-9
| -16% | -$5.67K | ﹤0.01% | 334 |
|
2021
Q3 | $33K | Sell |
55
-8
| -13% | -$4.8K | ﹤0.01% | 311 |
|
2021
Q2 | $35K | Hold |
63
| – | – | ﹤0.01% | 307 |
|
2021
Q1 | $30K | Buy |
63
+3
| +5% | +$1.43K | ﹤0.01% | 301 |
|
2020
Q4 | $29K | Buy |
+60
| New | +$29K | ﹤0.01% | 296 |
|
2018
Q2 | – | Sell |
-5,500
| Closed | -$1.89M | – | 209 |
|
2018
Q1 | $1.89M | Hold |
5,500
| – | – | ﹤0.01% | 198 |
|
2017
Q4 | $2.07M | Hold |
5,500
| – | – | ﹤0.01% | 192 |
|
2017
Q3 | $2.46M | Hold |
5,500
| – | – | ﹤0.01% | 190 |
|
2017
Q2 | $2.7M | Hold |
5,500
| – | – | ﹤0.01% | 190 |
|
2017
Q1 | $2.13M | Hold |
5,500
| – | – | ﹤0.01% | 187 |
|
2016
Q4 | $2.02M | Sell |
5,500
-4,600
| -46% | -$1.69M | ﹤0.01% | 194 |
|
2016
Q3 | $4.06M | Hold |
10,100
| – | – | 0.01% | 182 |
|
2016
Q2 | $3.53M | Hold |
10,100
| – | – | 0.01% | 179 |
|
2016
Q1 | $3.64M | Sell |
10,100
-2,600
| -20% | -$937K | 0.01% | 180 |
|
2015
Q4 | $6.89M | Sell |
12,700
-7,900
| -38% | -$4.29M | 0.01% | 154 |
|
2015
Q3 | $9.58M | Hold |
20,600
| – | – | 0.02% | 150 |
|
2015
Q2 | $10.5M | Hold |
20,600
| – | – | 0.02% | 144 |
|
2015
Q1 | $9.3M | Hold |
20,600
| – | – | 0.02% | 153 |
|
2014
Q4 | $8.45M | Hold |
20,600
| – | – | 0.02% | 156 |
|
2014
Q3 | $7.43M | Sell |
20,600
-16,180
| -44% | -$5.83M | 0.02% | 160 |
|
2014
Q2 | $10.4M | Hold |
36,780
| – | – | 0.02% | 152 |
|
2014
Q1 | $11M | Hold |
36,780
| – | – | 0.03% | 143 |
|
2013
Q4 | $10.1M | Sell |
36,780
-2,672
| -7% | -$735K | 0.02% | 141 |
|
2013
Q3 | $12.3M | Buy |
39,452
+37,780
| +2,260% | +$11.8M | 0.03% | 130 |
|
2013
Q2 | $376K | Buy |
+1,672
| New | +$376K | ﹤0.01% | 152 |
|